CONFLUENCE INVESTMENT MANAGEMENT LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,096 filers reported holding NOVARTIS A G in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
CONFLUENCE INVESTMENT MANAGEMENT LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2022$15,769,000
-1.6%
186,547
+2.2%
0.25%
+9.8%
Q1 2022$16,023,000
+0.7%
182,602
+0.4%
0.22%
+6.2%
Q4 2021$15,913,000
-13.2%
181,928
-18.9%
0.21%
-17.9%
Q3 2021$18,338,000
-24.3%
224,239
-15.5%
0.26%
-20.2%
Q2 2021$24,213,000
+12.9%
265,378
+5.8%
0.32%
+7.0%
Q1 2021$21,441,000
-8.1%
250,831
+1.5%
0.30%
-13.3%
Q4 2020$23,336,000
+6.9%
247,124
-1.5%
0.35%
-2.3%
Q3 2020$21,828,000
-1.4%
251,014
-1.0%
0.36%
-4.1%
Q2 2020$22,142,000
+7.1%
253,518
+1.1%
0.37%
-5.9%
Q1 2020$20,682,000
-1.8%
250,838
+8.8%
0.39%
+16.6%
Q4 2019$21,055,000
+0.0%
230,583
-4.8%
0.34%
+2.7%
Q3 2019$21,052,000
-0.0%
242,254
+5.1%
0.33%
-2.7%
Q2 2019$21,055,000
+0.2%
230,583
+5.5%
0.34%
-5.1%
Q1 2019$21,008,000
+14.3%
218,512
+2.0%
0.36%
+2.6%
Q4 2018$18,385,000
+12.4%
214,250
+12.8%
0.35%
+24.0%
Q3 2018$16,361,000
+21.0%
189,895
+6.1%
0.28%
+17.2%
Q2 2018$13,518,000
-1.4%
178,954
+5.6%
0.24%
-5.9%
Q1 2018$13,704,000
-0.3%
169,499
+3.6%
0.25%
+0.8%
Q4 2017$13,740,000
+0.5%
163,650
+2.7%
0.25%
-4.2%
Q3 2017$13,676,000
+7.3%
159,300
+4.4%
0.26%
+1.2%
Q2 2017$12,742,000
+18.4%
152,658
+5.3%
0.26%
+7.9%
Q1 2017$10,765,000
+15.3%
144,940
+13.1%
0.24%
+5.7%
Q4 2016$9,335,000
+2.4%
128,163
+11.0%
0.23%
-4.6%
Q3 2016$9,119,000
+3.9%
115,487
+8.6%
0.24%
-1.2%
Q2 2016$8,777,000
+27.2%
106,371
+11.7%
0.24%
+16.4%
Q1 2016$6,900,000
-8.5%
95,250
+8.7%
0.21%
-16.2%
Q4 2015$7,542,000
+2.1%
87,658
+9.1%
0.25%
-8.2%
Q3 2015$7,385,000
-6.9%
80,339
-0.4%
0.27%
-6.9%
Q2 2015$7,929,000
+2.2%
80,631
+2.5%
0.29%
-1.4%
Q1 2015$7,757,000
+13.4%
78,660
+6.5%
0.29%
+5.0%
Q4 2014$6,843,000
+4.5%
73,846
+6.2%
0.28%
-4.5%
Q3 2014$6,547,000
+12.7%
69,549
+8.4%
0.29%
+9.8%
Q2 2014$5,807,000
+14.0%
64,149
+7.0%
0.27%
+3.1%
Q1 2014$5,096,000
+16.8%
59,935
+10.4%
0.26%
+7.1%
Q4 2013$4,363,000
+27.0%
54,280
+21.2%
0.24%
+13.1%
Q3 2013$3,435,000
+21.6%
44,776
+12.1%
0.21%
+9.8%
Q2 2013$2,824,00039,9370.19%
Other shareholders
NOVARTIS A G shareholders Q2 2019
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders